Experimental Evaluation of Geocell and EPS Geofoam as Means of Protecting Pipes at the Bottom of Repeatedly Loaded Trenches

© 2020 American Society of Civil Engineers. With growing populations and continuing urban development, embedding pipes in the ground that are then overrun by traffic is inevitable. This paper describes full-scale prototype tests on high-density polyethylene (HDPE) flexible pipes (of 250 mm diameter), buried at shallow depth, under simulated traffic loading. The paper studies the effect of surface load diameter (0.6×, 0.8×, and 1× pipe diameter) and the amplitude of repeated load (400 or 800 kPa) on pipe behavior. The effects of expanded polystyrene (EPS) geofoam blocks of various densities and also of geocells as a three-dimensional (3D) reinforcement in reducing the pressure transferred to the pipe, the deformation of the pipe, and the surface settlement of the backfill were investigated. The results show that, with an increase in loading surface diameter, the pipe's vertical diametral strain, the pressure transferred to the pipe, and the surface settlement grow significantly, irrespective of applied pressure. Using an EPS block over the pipe increases the soil settlement but reduces transferred pressure onto the pipe and, consequentially, results in lower pipe deformations. The increase in density of an EPS block helps improve response but was still found to be insufficient to prevent increase in surface deflections. The use of geocell reinforcement beneath the loading surface not only reduces the pressure transferred to the pipe and decreases its deformation but also significantly negates the tendency of the EPS block to increase the soil surface settlement. Thus, a geocell reinforcement layer placed over two EPS geofoam blocks (with total thickness 0.3× and width 1.5× the pipe diameter) all above a pipe buried at a depth of twice the pipe diameter, was found to deliver an acceptable, stable response. By these means, the vertical pipe strain, transferred pressure over the pipe, and soil surface settlement were reduced, respectively, by 0.45, 0.37, and 0.53× those obtained for the comparable unmodified buried pipe installation and are within allowable limits

Behavior of expanded polystyrene (EPS) blocks under cyclic pavement foundation loading

This study introduces a mechanism for initial assessment and future development to improve understanding of expanded polystyrene (EPS) behavior as a super-lightweight material for road construction. Large scale cyclic plate load tests on model pavements were performed. The effect of several factors including thickness of soil, thickness of subsequent EPS layers and density of EPS on the surface deformations, resilient modulus (Mr) and interlayer pressure transfer were investigated. The results indicated that, compared to a covering soil layer of 300 mm, the rut depth on the loading surface reduced by 13.5% and 40.8% when the soil thickness was increased by 33% and 100%, respectively. With a constant soil thickness, increasing the thickness of an upper (denser) EPS layer with respect to a bottom (softer) EPS layer, from 200 mm to 600 mm, would only result in a 20% decrease in the peak settlements after loading. Resilient modulus of the system was found to be dependent on soil thickness. A designer can choose an appropriate resilient modulus assuming the soil-EPS composite acts as subgrade or subbase. In order to extend the results to a wider range of geofoams, soils and layer thicknesses, a simple stress analysis method was also trialed

Spatial Asymmetric Two dimensional Continuous Abelian Sandpile Model

We insert some asymmetries in the continuous Abelian sandpile models, such as directedness and ellipticity. We analyze probability distribution of different heights and also find the field theory corresponding to the models. Also we find the fields associated with some height variables.Comment: 14 Pages, 11 Figure

Logarithmic two-point correlators in the Abelian sandpile model

We present the detailed calculations of the asymptotics of two-site correlation functions for height variables in the two-dimensional Abelian sandpile model. By using combinatorial methods for the enumeration of spanning trees, we extend the well-known result for the correlation $\sigma_{1,1} \simeq 1/r^4$ of minimal heights $h_1=h_2=1$ to $\sigma_{1,h} = P_{1,h}-P_1P_h$ for height values $h=2,3,4$. These results confirm the dominant logarithmic behaviour $\sigma_{1,h} \simeq (c_h\log r + d_h)/r^4 + {\cal O}(r^{-5})$ for large $r$, predicted by logarithmic conformal field theory based on field identifications obtained previously. We obtain, from our lattice calculations, the explicit values for the coefficients $c_h$ and $d_h$ (the latter are new).Comment: 28 page

Abelian Sandpile Model on the Honeycomb Lattice

We check the universality properties of the two-dimensional Abelian sandpile model by computing some of its properties on the honeycomb lattice. Exact expressions for unit height correlation functions in presence of boundaries and for different boundary conditions are derived. Also, we study the statistics of the boundaries of avalanche waves by using the theory of SLE and suggest that these curves are conformally invariant and described by SLE2.Comment: 24 pages, 5 figure

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50.

Purpose We report the first 5-year follow-up of any first-line phase III immunotherapy trial for non-small-cell lung cancer (NSCLC). KEYNOTE-024 (ClinicalTrials.gov identifier: NCT02142738) is an open-label, randomized controlled trial of pembrolizumab compared with platinum-based chemotherapy in patients with previously untreated NSCLC with a programmed death ligand-1 (PD-L1) tumor proportion score of at least 50% and no sensitizing EGFR or ALK alterations. Previous analyses showed pembrolizumab significantly improved progression-free survival and overall survival (OS).Methods Eligible patients were randomly assigned (1:1) to pembrolizumab (200 mg once every 3 weeks for up to 35 cycles) or platinum-based chemotherapy. Patients in the chemotherapy group with progressive disease could cross over to pembrolizumab. The primary end point was progression-free survival; OS was a secondary end point.Results Three hundred five patients were randomly assigned: 154 to pembrolizumab and 151 to chemotherapy. Median (range) time from randomization to data cutoff (June 1, 2020) was 59.9 (55.1-68.4) months. Among patients initially assigned to chemotherapy, 99 received subsequent anti-PD-1 or PD-L1 therapy, representing a 66.0% effective crossover rate. Median OS was 26.3 months (95% CI, 18.3-40.4) for pembrolizumab and 13.4 months (9.4-18.3) for chemotherapy (hazard ratio, 0.62; 95% CI, 0.48-0.81). Kaplan-Meier estimates of the 5-year OS rate were 31.9% for the pembrolizumab group and 16.3% for the chemotherapy group. Thirty-nine patients received 35 cycles (ie, approximately 2 years) of pembrolizumab, 82.1% of whom were still alive at data cutoff (approximately 5 years). Toxicity did not increase with longer treatment exposure.Conclusion Pembrolizumab provides a durable, clinically meaningful long-term OS benefit versus chemotherapy as first-line therapy for metastatic NSCLC with PD-L1 tumor proportion score of at least 50%

Integration of Optical Coherence Tomography Scan Patterns to Augment Clinical Data Suite

Vision changes identified in long duration spaceflight astronauts has led Space Medicine at NASA to adopt a more comprehensive clinical monitoring protocol. Optical Coherence Tomography (OCT) was recently implemented at NASA, including on board the International Space Station in 2013. NASA is collaborating with Heidelberg Engineering to increase the fidelity of the current OCT data set by integrating the traditional circumpapillary OCT image with radial and horizontal block images at the optic nerve head. The retinal nerve fiber layer was segmented by two experienced individuals. Intra-rater (N=4 subjects and 70 images) and inter-rater (N=4 subjects and 221 images) agreement was performed. The results of this analysis and the potential benefits will be presented

Abelian Manna model on various lattices in one and two dimensions

We perform a high-accuracy moment analysis of the avalanche size, duration and area distribution of the Abelian Manna model on eight two-dimensional and four one-dimensional lattices. The results provide strong support to establish universality of exponents and moment ratios across different lattices and a good survey for the strength of corrections to scaling which are notorious in the Manna universality class. The results are compared against previous work done on Manna model, Oslo model and directed percolation. We also confirm hypothesis of various scaling relations.Comment: 16 pages, 3 figures, 7 tables, submitted to Journal of Statistical Mechanic

Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis

BACKGROUND: Numerous observational studies suggest that preventable adverse drug reactions are a significant burden in healthcare, but no meta-analysis using a standardised definition for adverse drug reactions exists. The aim of the study was to estimate the percentage of patients with preventable adverse drug reactions and the preventability of adverse drug reactions in adult outpatients and inpatients. METHODS: Studies were identified through searching Cochrane, CINAHL, EMBASE, IPA, Medline, PsycINFO and Web of Science in September 2010, and by hand searching the reference lists of identified papers. Original peer-reviewed research articles in English that defined adverse drug reactions according to WHO's or similar definition and assessed preventability were included. Disease or treatment specific studies were excluded. Meta-analysis on the percentage of patients with preventable adverse drug reactions and the preventability of adverse drug reactions was conducted. RESULTS: Data were analysed from 16 original studies on outpatients with 48797 emergency visits or hospital admissions and from 8 studies involving 24128 inpatients. No studies in primary care were identified. Among adult outpatients, 2.0% (95% confidence interval (CI): 1.2-3.2%) had preventable adverse drug reactions and 52% (95% CI: 42-62%) of adverse drug reactions were preventable. Among inpatients, 1.6% (95% CI: 0.1-51%) had preventable adverse drug reactions and 45% (95% CI: 33-58%) of adverse drug reactions were preventable. CONCLUSIONS: This meta-analysis corroborates that preventable adverse drug reactions are a significant burden to healthcare among adult outpatients. Among both outpatients and inpatients, approximately half of adverse drug reactions are preventable, demonstrating that further evidence on prevention strategies is required. The percentage of patients with preventable adverse drug reactions among inpatients and in primary care is largely unknown and should be investigated in future research